Fair Value Disclosures (Tables)

6 Months Ended

Jun. 30, 2017

Schedule of financial instruments measured at fair value

Disclosures concerning financial instruments measured at fair value are as follows:



	Fair Value Measurements as of
	June 30, 2017								December 31, 2016
	Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total		Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Liabilities:
Derivative financial instruments	$	—	$	647	$	—	$	647	$	—	$	1,099	$	—	$	1,099
Mezzanine:
Redeemable noncontrolling interests (Company)/Redeemable limited partners (Operating Partnership)	$	—	$	55,344	$	—	$	55,344	$	—	$	55,078	$	—	$	55,078

Schedule of estimated fair value and related carrying amounts of mortgage loans and bonds payable

The table below contains the estimated fair value and related carrying amounts for the Company’s financial instruments as of June 30, 2017 and December 31, 2016:



	June 30, 2017					December 31, 2016
	Estimated Fair Value		Carrying Amount			Estimated Fair Value		Carrying Amount
Assets:
Loans receivable	$	54,396	$	60,202		$	54,396	$	58,539
Liabilities:
Unsecured notes	$	1,234,500	$	1,189,775	⁽¹⁾	$	1,211,344	$	1,188,737	⁽¹⁾
Mortgage loans payable	638,317		646,397		⁽²⁾	644,617		654,794		⁽²⁾
Bonds payable	36,591		33,448			37,066		33,401


⁽¹⁾	Includes net unamortized OID and net unamortized deferred financing costs (see Note 7).


⁽²⁾	Includes net unamortized debt premiums and discounts and net unamortized deferred financing costs (see Note 7).